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Alpha- and beta-adrenergic stimulation of human iryometrial activity
in-vitro and synthesis of prostagland,ins (PG E2/PG'^2a/6"^eto^gGF1a)
Quaas,L., H.P.Zahradnik
Beta-adrenergic stimalants inhibit spontaneous and induced uterine
contractions. Despite numerous clinical and experimental data the
mechanism of their action is still uncertain * Possible factors are
the activation of adenylate cyclase reducing myosin light chain
phosphorylation and intracellular calcium concentrations, their in-
fluence on the system of ion transport and the oxytocin-oxytocinase
system. Since in the regulation of uterine motor activity prosta-
glandins play a basic role it is also conceivable that the effect
of beta-adrenergic agonists takes place by modulating the synthesis
of prostaglandins. In our investigations the effects of adrenaline
and different alpha- and beta-adrenergic agonists and antagonists
on the mechanical activity and prostaglandin biosynthesis in the
pregnant human myometrium in-vitro were determined.
Pregnant human myometrial samples were excised from the edge of
surgical incision in cesarean sections. The myometrial strips (n=23)
were superfused with oxygenated tyrode solution and fractionated in
5 min. intervals. The medium was analyzed for prostaglandin E 2,
prostaglandin F 2 a, 6-keto-prostaglandin F 1 a by specific radio-
immunoassays.
In the first series of investigations the effect of adrenaline and
noradrenaline on the spontaneous activity of pregnant human myome-
trial strips were coirpared. Both adrenaline and noradrenaline sti-
mulated the myometrium to contract (1o ng/ml, 1oo ng/ml, 1 g/Inl) .
The dose dependent stimulation of the uterine activity correlated
with increasing prostaglandin synthesis of the myometrium strips.
Compared to the basal concentrations during spontaneous activity
there was a highly significant increase o f P G E 2 > P G F 2 a >
6-keto PG F 1 a during adrenergic stimulation (table).
In further studies the influence of alpha- and beta-adrenergic
antagonists on the adrenaline effect was investigated. The stimula-
ting effect of adrenaline could be inhibited by specific alpha-
blocking substances like phentolamin, prazosine and yohimbine.
This inhibition of the alpha-adrenergic activity of adrenaline was
associated with low levels of PG F 2 a and PG E 2 coitparable to
those concentrations that were measured without adrenaline stimula-
tion. Coinciding with the now reduced and inhibiting adrenaline ef-
fect an increase of 6-keto-PG F 1 a formation was measured (table).
Orciprenaline a beta-stimulating agent had the sane effect. It inhi-
bited the synthesis of PG F 2 a and PG E 2 and the stimulation of
prostacyclin synthesis was the irost expressed.
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Superfusion of the myometrium strips with adrenaline together with
the beta-adrenergic antagonist pindolole had a strong contractions
stimulating effect and resulted in an increase of the PG E 2 and
PG F 2 a and a decrease of 6-keto-PG F 1 a synthesis. This effect
was even more pronounced by \asing norfenephrine a specific alpha-
adrenergic agonist with a marked stimulatory effect on PG E 2 and
PG F 2 a synthesis.
The results demonstrate the dependency of human myometrial activity
on alpha- and beta-adrenergic stimulation. Stimulation of alpha-
receptors is responded by increased PG E 2 and PG F 2 a synthesis.
Stimulation of beta-receptors corresponds with relaxation and en-
hanced 6-keto-PG F 1 a formation. It is therefore concluded that
betamimetics are effective uterine relaxants by stimulating prosta-
cyclin synthesis.
Table: Effect of alpha- and beta-adrenergic stimulation on PG -
synthesis in isolated gestational human myometrial strips
PG F 2 a PG E 2 6-keto PG F 1 a
Ο.39+0.17 2.46+1.26 1.9O+O.37
1.83+0.21* 13.73+2.95* 5.77+O.94*
SPONTANEOUS ACTIVITY
ADRENALINE 1 ug/ml
ADRENALINE 1 μg/ml
PRAZOSINE 1 μg/ml
ADRENALINE 1 μg/Inl
YOHIMBINE 1 ug/ml
ADRENALINE 1 μg/Inl
PINDOLOLE 1 μg/ml
ORCIPRENALINE 1o ng/ml O.31+O.22 2.13+O.2O 7.O2+O.81
NORFENEPHRINE 5o ng/ml 18.72+1.85 33.19+2.6O 3.41+O.11
0.42+0.27 3.24+1.31 6.36+O.22
0.36+0.16 3.42+1.52 1O.51+1.81
10.84+1.93* 20.28+0.91* 5.74+1.06
Prostaglandin-concentration in ng/ml/g wet weight, _+ = SD,
* = p< O.O5
